5334:TSENiterra Co.,Ltd. Analysis
Data as of 2026-03-11 - not real-time
¥7,907.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Niterra Co., Ltd. is trading well above its 20‑day (≈7,550) and 200‑day (≈5,980) simple moving averages, confirming a bullish price trend despite a recent dip in volume. The RSI of around 63 indicates continued momentum but stays clear of overbought territory, while the MACD histogram is negative and the signal line suggests a short‑term bearish tilt. The current market price of roughly 7,900 JPY sits near the 52‑week high resistance of 8,062 JPY, leaving limited upside and a modest downside cushion. Fundamentally, the company posts an 8.6% revenue growth rate, solid profit margins above 14%, and a respectable ROE of nearly 15%, supporting its Buy consensus among analysts. However, the discounted cash‑flow model values the stock at about 6,700 JPY, implying a ~6% premium that renders the equity slightly overvalued relative to intrinsic estimates. The balance sheet shows a high cash pile offset by sizable debt, resulting in a net‑debt position that warrants monitoring, though the dividend yield of 2.4% and a payout ratio under 40% suggest sustainable shareholder returns. With a low beta of 0.56, the stock exhibits modest market volatility, yet recent 30‑day price swings exceed 38%, reflecting sector‑specific cyclicality. Overall, the blend of strong cash generation, decent valuation multiples, and a resilient dividend profile positions Niterra as a stable, income‑focused holding, while technical signals advise caution near the near‑term resistance level.
Investors should weigh the short‑term bearish cues against the longer‑term fundamentals. The dividend appears sustainable, and the company’s diversified product mix across automotive, semiconductor, and medical ceramics provides a defensive buffer against sector downturns. Given the current market optimism (Extreme Greed sentiment) and the modest overvaluation, a measured approach—holding or modest buying on dips—aligns with the risk‑adjusted upside potential.
Investors should weigh the short‑term bearish cues against the longer‑term fundamentals. The dividend appears sustainable, and the company’s diversified product mix across automotive, semiconductor, and medical ceramics provides a defensive buffer against sector downturns. Given the current market optimism (Extreme Greed sentiment) and the modest overvaluation, a measured approach—holding or modest buying on dips—aligns with the risk‑adjusted upside potential.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price approaching 52‑week resistance
- Bearish MACD signal
- Decreasing trading volume
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Solid revenue growth and profit margins
- Sustainable dividend yield
- Low market beta indicating stability
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong free cash flow generation
- Diversified product portfolio across cyclical and defensive segments
- Consistent dividend payout and attractive yield
Key Metrics & Analysis
Financial Health
Revenue Growth8.60%
Profit Margin14.67%
P/E Ratio16.4
ROE14.80%
ROA7.57%
Debt/Equity40.52
P/B Ratio2.1
Op. Cash Flow¥110.0B
Free Cash Flow¥69.1B
Technical Analysis
TrendBullish
RSI63.0
Support¥6,656.00
Resistance¥8,062.00
MA 20¥7,552.40
MA 50¥7,145.10
MA 200¥5,976.37
MACDBearish
VolumeDecreasing
Fear & Greed Index76.91
Valuation
Fair Value¥6,692.28
Target Price¥7,403.50
Upside/Downside-6.37%
GradeFair
TypeBlend
Dividend Yield2.41%
Risk Assessment
Beta0.56
Volatility38.62%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.